This is a good piece from Jerusalem Demsas on slowness at the FDA. One could add to this its botching of e-cig regulation. It's long past deadline and has authorized only one e-cig out of millions of applications, despite the clear safety advantage of vaping over smoking.
Is the FDA too cautious?
The pandemic revealed the flaws in the FDA’s risk assessments.
vox.com